Finance

Lists
COPN:SWX
Cosmo Pharmaceuticals NV
CHF 63.60
0.00%
(0.00) 1D
Jul 27, 11:05:06 AM GMT+2  ·   CHF
All symbols
SymbolPriceChange% Change
Generating top insights for COPN...
Open
CHF 64.80
High
CHF 64.80
Low
CHF 62.10
Mkt. cap
1.12B
Avg. vol.
33.37K
Volume
13.03K
Dividend
3.04%
Quarterly dividend
CHF 0.48
Ex-dividend date
Apr 24, 2026
52-wk high
CHF 129.40
52-wk low
CHF 53.40
EPS
-CHF 0.21
Shares outstanding
17.54M
No. of employees
325
Open
CHF 64.80
High
CHF 64.80
Low
CHF 62.10
Mkt. cap
1.12B
Avg. vol.
33.37K
Volume
13.03K
Dividend
3.04%
Quarterly dividend
CHF 0.48
Ex-dividend date
Apr 24, 2026
52-wk high
CHF 129.40
52-wk low
CHF 53.40
EPS
-CHF 0.21
Shares outstanding
17.54M
No. of employees
325
News stories
From sources across the web
About Cosmo Pharmaceuticals NV
CEO-
Employees325
Founded1997
Headquarters-
SectorPharmaceutical industry
Websitecosmohealthconfidence.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
26.23M
26.23M
25.12M
25.12M
Cost of goods sold
14.02M
14.02M
13.95M
13.95M
Cost of revenue
14.02M
14.02M
13.95M
13.95M
Research and development expenses
8.09M
8.09M
7.57M
7.57M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
6.27M
6.27M
8.32M
8.32M
Operating expense
14.97M
14.97M
14.47M
14.47M
Total operating expenses
28.99M
28.99M
28.42M
28.42M
Operating income
-2.76M
-2.76M
-3.30M
-3.30M
Other non operating income
-13.00K
-13.00K
1.61M
1.61M
EBT including unusual items
-124.00K
-124.00K
-1.89M
-1.89M
EBT excluding unusual items
-916.00K
-916.00K
-1.89M
-1.89M
Income tax expense
606.00K
606.00K
471.50K
471.50K
Effective tax rate
-488.71%
-488.71%
-24.89%
-24.89%
Other operating expenses
611.00K
611.00K
-1.42M
-1.42M
Net income
-801.00K
-801.00K
-2.38M
-2.38M
Net profit margin
-3.05%
-3.05%
-9.46%
-9.46%
Earnings per share
-
-
-
-
Interest and investment income
2.02M
2.02M
-
-
Interest expense
-28.50K
-28.50K
-202.00K
-202.00K
Net interest expenses
1.99M
1.99M
-202.00K
-202.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
104.50K
104.50K
-2.50K
-2.50K
Gain or loss from assets sale
13.00K
13.00K
-
-
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer